1. GPVI inhibition by glenzocimab synergistically inhibits atherosclerotic plaque-induced platelet activation when combined with conventional dual antiplatelet therapy. (14th October 2021) Authors: Alenazy, F O; Harbi, M H; Kavanagh, D P; Price, J; Brady, P; Hargreaves, O; Harrison, P H; Slater, A; Connolly, D L; Kirchhof, P; Kalia, N; Jandrot-Perrus, M; Mangin, P H; Watson, S P; Thomas, M R Journal: European heart journal Issue: Volume 42(2021)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗